Vital Farms Reports Second Quarter 2025 Financial Results
Second Quarter Net Revenue of
Raises Fiscal Year 2025 Net Revenue Outlook to At Least
On Track to Reach
Financial highlights for the second quarter ended
-
Net Revenue increased 25.4% to
$184.8 million , compared to$147.4 million - Gross Margin of 38.9%, compared to 39.1%
-
Net Income of
$16.6 million , compared to$16.3 million -
Net Income per Diluted Share of
$0.36 , compared to$0.36 -
Adjusted EBITDA of
$29.9 million ,compared to$23.3 million 1
"We delivered second quarter results that exceeded our initial expectations, demonstrating the overall strength of our business model and expanding year-over-year consumer awareness of our strong brand," said
1Adjusted EBITDA is a non-GAAP financial measure defined in the section titled “Non-GAAP Financial Measures” below and is reconciled to net income, its closest comparable GAAP measure, at the end of this release.
For the 13 Weeks Ended
Net revenue increased 25.4% to
Gross profit was
Income from operations was
Net income was
Net income per diluted share was
Adjusted EBITDA was
Adjusted EBITDA excludes certain non-cash items. Adjusted EBITDA is a non-GAAP financial measure defined in the section titled “Non-GAAP Financial Measures” below and is reconciled to net income, its closest comparable GAAP measure, at the end of this release.
Balance Sheet and Cash Flow Highlights
Cash, cash equivalents and marketable securities were
Capital expenditures totaled
Fiscal 2025 Outlook
For fiscal year 2025, we now expect:
-
Net revenue of at least
$770 million , which represents at least 27% growth versus fiscal year 2024 results, an increase from previous guidance of at least$740 million . -
Adjusted EBITDA of at least
$110 million , which represents at least 26% growth versus fiscal year 2024, an increase from previous guidance of at least$100 million . -
Capital expenditures in the range of
$90 million to$110 million , an increase from our previous guidance of$50 to$60 million . This increase reflects our strategic decision to construct both production lines at ourSeymour, Indiana facility simultaneously rather than in phases, and add onsite cold storage, which we believe will provide us with sufficient capacity to supply future expected demand and also optimize our capital efficiency on a per-square-foot basis. Our capital expenditure plans continue to also support investments in our new production line atEgg Central Station inSpringfield , our accelerator farms, and our Digital Transformation project, which remains on track to go live in early Fall 2025. We continue to evaluate our capital allocation priorities, and we will provide updates as necessary in future earnings reports.
Vital Farms’ guidance assumes that there are no significant disruptions to the supply chain or its customers or consumers, including any issues from adverse macroeconomic factors.
Conference Call and Webcast Details
In addition,
About
Forward-Looking Statements
This press release and the earnings call referencing this press release contain “forward-looking” statements, as that term is defined under the federal securities laws, including but not limited to statements regarding Vital Farms’ market opportunity, brand strength, anticipated growth, expectations regarding supply constraints, timing regarding Vital Farms’ Digital Transformation project, specifications and timing regarding Vital Farms’ planned egg washing and packing facility in
The risks and uncertainties referred to above include, but are not limited to: Vital Farms’ expectations regarding its revenue, expenses, and other operating results; Vital Farms’ ability to attract new customers, to successfully retain existing customers, to attract and retain its suppliers, distributors, and co-manufacturers, and to maintain its relationships with members of its existing farm network and further expand its farm network and development of its accelerator farms; Vital Farms’ ability to sustain or increase its profitability; Vital Farms’ expectations regarding its future growth in the foodservice channel; Vital Farms’ ability to procure sufficient high-quality eggs, cream for its butter, and other raw materials; real or perceived quality or food safety issues with Vital Farms’ products or other issues that adversely affect Vital Farms’ brand and reputation; changes in the tastes and preferences of consumers; the financial condition of, and Vital Farms’ relationships with, its farmers, suppliers, co-manufacturers, distributors, retailers, and foodservice customers, as well as the health of the foodservice industry generally; the effects of outbreaks of agricultural diseases, including avian influenza and egg drop syndrome, the perception that outbreaks may occur or regulatory or market responses to such outbreaks generally; the ability of
These risks and uncertainties are more fully described in Vital Farms’ filings with the
|
||||||||||||||||
13-Weeks Ended |
26-Weeks Ended |
|||||||||||||||
|
|
|
|
|||||||||||||
Net revenue |
$ |
184,767 |
|
$ |
147,388 |
|
$ |
346,956 |
|
$ |
295,316 |
|
||||
Cost of goods sold |
|
112,985 |
|
|
89,710 |
|
|
212,661 |
|
|
178,742 |
|
||||
Gross profit |
|
71,782 |
|
|
57,678 |
|
|
134,295 |
|
|
116,574 |
|
||||
Operating expenses: |
||||||||||||||||
Selling, general and administrative |
|
38,987 |
|
|
33,336 |
|
|
70,897 |
|
|
60,467 |
|
||||
Shipping and distribution |
|
9,000 |
|
|
7,203 |
|
|
17,835 |
|
|
14,799 |
|
||||
Total operating expenses |
|
47,987 |
|
|
40,539 |
|
|
88,732 |
|
|
75,266 |
|
||||
Income from operations |
|
23,795 |
|
|
17,139 |
|
|
45,563 |
|
|
41,308 |
|
||||
Other income (expense), net: |
||||||||||||||||
Interest expense |
|
(218 |
) |
|
(257 |
) |
|
(453 |
) |
|
(512 |
) |
||||
Interest income |
|
1,332 |
|
|
1,316 |
|
|
2,544 |
|
|
2,404 |
|
||||
Other expense, net |
|
(378 |
) |
|
(87 |
) |
|
(781 |
) |
|
(364 |
) |
||||
Total other income (expense), net |
|
736 |
|
|
972 |
|
|
1,310 |
|
|
1,528 |
|
||||
Net income before income taxes |
|
24,531 |
|
|
18,111 |
|
|
46,873 |
|
|
42,836 |
|
||||
Income tax provision |
|
7,893 |
|
|
1,772 |
|
|
13,334 |
|
|
7,474 |
|
||||
Net income |
$ |
16,638 |
|
$ |
16,339 |
|
$ |
33,539 |
|
$ |
35,362 |
|
||||
Net income per share: |
||||||||||||||||
Basic: |
$ |
0.37 |
|
$ |
0.38 |
|
$ |
0.76 |
|
$ |
0.84 |
|
||||
Diluted: |
$ |
0.36 |
|
$ |
0.36 |
|
$ |
0.73 |
|
$ |
0.79 |
|
||||
Weighted average common shares outstanding: |
||||||||||||||||
Basic: |
|
44,591,484 |
|
|
42,500,355 |
|
|
44,421,116 |
|
|
42,148,992 |
|
||||
Diluted: |
|
45,804,158 |
|
|
45,248,792 |
|
|
45,815,874 |
|
|
44,600,401 |
|
|
||||||
|
|
|||||
(Unaudited) |
||||||
Assets |
||||||
Current assets: |
||||||
Cash and cash equivalents |
$ |
108,224 |
$ |
150,601 |
||
Investment securities, available-for-sale |
|
46,773 |
|
9,692 |
||
Accounts receivable, net of allowance for credit losses of |
|
68,405 |
|
54,342 |
||
Inventories |
|
42,710 |
|
23,666 |
||
Prepaid expenses and other current assets, net of allowance for credit losses of |
|
6,428 |
|
7,740 |
||
Assets held for sale |
|
2,667 |
|
— |
||
Total current assets |
|
275,207 |
|
246,041 |
||
Property, plant and equipment, net |
|
111,155 |
|
84,521 |
||
Operating lease right-of-use assets |
|
31,196 |
|
19,617 |
||
|
|
13,194 |
|
9,153 |
||
Total assets |
$ |
430,752 |
$ |
359,332 |
||
Liabilities and Stockholders’ Equity |
||||||
Current liabilities: |
||||||
Accounts payable |
$ |
66,352 |
$ |
38,582 |
||
Accrued liabilities |
|
34,037 |
|
31,328 |
||
Operating lease liabilities, current |
|
5,368 |
|
3,849 |
||
Finance lease liabilities, current |
|
4,401 |
|
3,932 |
||
Income taxes payable |
|
690 |
|
838 |
||
Total current liabilities |
|
110,848 |
|
78,529 |
||
Operating lease liabilities, non-current |
|
1,361 |
|
2,918 |
||
Finance lease liabilities, non-current |
|
6,458 |
|
8,011 |
||
Other liabilities |
|
2,307 |
|
572 |
||
Total liabilities |
$ |
120,974 |
$ |
90,030 |
||
Commitments and contingencies |
||||||
Stockholders’ equity: |
||||||
Preferred stock, |
|
— |
|
— |
||
Common stock, |
|
4 |
|
4 |
||
Additional paid-in capital |
|
193,119 |
|
186,182 |
||
Retained earnings |
|
116,652 |
|
83,113 |
||
Accumulated other comprehensive income |
|
3 |
|
3 |
||
Total stockholders’ equity |
$ |
309,778 |
$ |
269,302 |
||
Total liabilities and stockholders’ equity |
$ |
430,752 |
$ |
359,332 |
|
||||||||
26-Weeks Ended |
||||||||
|
|
|||||||
Cash flows from operating activities: |
||||||||
Net income |
$ |
33,539 |
|
$ |
35,362 |
|
||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Depreciation and amortization |
|
6,727 |
|
|
6,499 |
|
||
Reduction in the carrying amount of right-of-use assets |
|
3,691 |
|
|
1,658 |
|
||
Amortization of available-for-sale debt securities |
|
(296 |
) |
|
76 |
|
||
Amortization of debt issuance costs |
|
43 |
|
|
19 |
|
||
Stock-based compensation expense |
|
5,887 |
|
|
4,898 |
|
||
Deferred taxes |
|
(24 |
) |
|
— |
|
||
Uncertain tax positions |
|
1,735 |
|
|
— |
|
||
Net realized losses on derivative instruments |
|
822 |
|
|
346 |
|
||
Other |
|
1,293 |
|
|
(132 |
) |
||
Net change in operating assets and liabilities |
|
(48,904 |
) |
|
(8,644 |
) |
||
Net cash provided by operating activities |
$ |
4,513 |
|
$ |
40,082 |
|
||
Cash flows from investing activities: |
||||||||
Purchases of property, plant and equipment |
|
(9,994 |
) |
|
(6,914 |
) |
||
Purchases and settlements of derivative instruments |
|
264 |
|
|
(669 |
) |
||
Purchases of available-for-sale securities |
|
(45,079 |
) |
|
— |
|
||
Maturities and call redemptions of available-for-sale debt securities |
|
7,890 |
|
|
13,335 |
|
||
Proceeds from the sale of available-for-sale debt securities |
|
404 |
|
|
|
— |
|
|
Proceeds from the sale of property, plant and equipment |
|
608 |
|
|
1 |
|
||
Net cash (used in) provided by investing activities |
$ |
(45,907 |
) |
$ |
5,753 |
|
||
Cash flows from financing activities: |
||||||||
Proceeds from exercise of stock options |
|
3,649 |
|
|
6,448 |
|
||
Proceeds from issuance of common stock under employee stock purchase plan |
|
379 |
|
|
178 |
|
||
Payment of tax withholding obligation on vested restricted stock unit shares |
|
(2,978 |
) |
|
(1,351 |
) |
||
Principal payments under finance lease obligations |
|
(2,033 |
) |
|
(1,672 |
) |
||
Payment of financing costs |
|
— |
|
|
(414 |
) |
||
Net cash (used in) provided by financing activities |
$ |
(983 |
) |
$ |
3,189 |
|
||
Net (decrease) increase in cash and cash equivalents |
|
(42,377 |
) |
|
49,024 |
|
||
Cash and cash equivalents at beginning of the period |
|
150,601 |
|
|
84,149 |
|
||
Cash and cash equivalents at end of the period |
$ |
108,224 |
|
$ |
133,173 |
|
||
Supplemental disclosure of cash flow information: |
||||||||
Cash paid for interest |
$ |
410 |
|
$ |
512 |
|
||
Cash paid for income taxes |
|
11,772 |
|
|
11,344 |
|
||
Supplemental disclosure of non-cash investing and financing activities: |
||||||||
Purchases of property, plant and equipment included in accounts payable and accrued liabilities |
$ |
25,590 |
|
$ |
150 |
|
Non-GAAP Financial Measures
We report our financial results in accordance with GAAP. However, management believes that Adjusted EBITDA and Adjusted EBITDA Margin, non-GAAP financial measures, provide investors with additional useful information in evaluating our performance.
Adjusted EBITDA and Adjusted EBITDA Margin are financial measures that are not required by or presented in accordance with GAAP. We believe that Adjusted EBITDA and Adjusted EBITDA Margin, when taken together with our financial results presented in accordance with GAAP, provide meaningful supplemental information regarding our operating performance and facilitate internal comparisons of our historical operating performance on a more consistent basis by excluding certain items that may not be indicative of our business, results of operations or outlook. In particular, we believe that the use of Adjusted EBITDA and Adjusted EBITDA Margin are helpful to our investors as they are measures used by management in assessing the health of our business, determining incentive compensation and evaluating our operating performance, as well as for internal planning and forecasting purposes. We calculate Adjusted EBITDA as net income, adjusted to exclude: (1) depreciation and amortization; (2) stock-based compensation expense; (3) (benefit) or provision for income taxes as applicable; (4) interest expense; and (5) interest income. We calculate Adjusted EBITDA Margin as Adjusted EBITDA divided by Net Revenue.
Adjusted EBITDA and Adjusted EBITDA Margin are presented for supplemental informational purposes only, have limitations as analytical tools and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. Some of the limitations of Adjusted EBITDA and Adjusted EBITDA Margin include that (1) they do not properly reflect capital commitments to be paid in the future, (2) although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and Adjusted EBITDA and Adjusted EBITDA Margin do not reflect these capital expenditures, (3) they do not consider the impact of stock-based compensation expense, (4) they do not reflect other non-operating expenses, including interest expense; and (5) they do not reflect tax payments that may represent a reduction in cash available to us. In addition, our use of Adjusted EBITDA and Adjusted EBITDA Margin may not be comparable to similarly titled measures of other companies because they may not calculate Adjusted EBITDA and Adjusted EBITDA Margin in the same manner, limiting the usefulness as comparative measures. Because of these limitations, when evaluating our performance, you should consider Adjusted EBITDA and Adjusted EBITDA Margin alongside other financial measures, including our net income and other results stated in accordance with GAAP.
|
||||||||||||||||||||
13-Weeks Ended |
26-Weeks Ended |
|||||||||||||||||||
|
|
|
|
|||||||||||||||||
(in thousands) |
(in thousands) |
|||||||||||||||||||
Net income |
$ |
16,638 |
|
$ |
16,339 |
|
$ |
33,539 |
|
$ |
35,362 |
|
||||||||
Depreciation and amortization(1) |
|
3,468 |
|
|
3,288 |
|
|
6,727 |
|
|
6,499 |
|
||||||||
Stock-based compensation expense |
|
3,034 |
|
|
2,916 |
|
|
5,887 |
|
|
4,898 |
|
||||||||
Income tax provision |
|
7,893 |
|
|
1,772 |
|
|
13,334 |
|
|
7,474 |
|
||||||||
Interest expense |
|
218 |
|
|
257 |
|
|
453 |
|
|
512 |
|
||||||||
Interest income |
|
(1,332 |
) |
|
(1,316 |
) |
|
(2,544 |
) |
|
(2,404 |
) |
||||||||
Adjusted EBITDA |
$ |
29,919 |
|
$ |
23,256 |
|
$ |
57,396 |
|
$ |
52,341 |
|
||||||||
Net revenue |
$ |
184,767 |
|
$ |
147,388 |
|
$ |
346,956 |
|
$ |
295,316 |
|
||||||||
Net income margin(2) |
|
9.0 |
% |
|
11.1 |
% |
|
9.7 |
% |
|
12.0 |
% |
||||||||
Adjusted EBITDA Margin(3) |
|
16.2 |
% |
|
15.8 |
% |
|
16.5 |
% |
|
17.7 |
% |
||||||||
1 |
Amount also includes finance lease amortization. |
||||
2 |
Net income margin is calculated by dividing net income by net revenue. |
||||
3 |
Adjusted EBITDA Margin is calculated by dividing Adjusted EBITDA by net revenue. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250807966613/en/
Media:
Rob.Discher@vitalfarms.com
Investors:
ICR
John.Mills@icrinc.com
Source: